IO Biotech Q3 2025 Earnings EPS Beat of 6067 Surprise but No Revenue from PreCommercial Pipeline ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending SID Q1 2026 Earnings Steelmaker Reports WiderthanExpected Loss Shares Rise Despite Miss CVLT Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response NRP Q1 2026 Earnings LP Reports Solid EPS Amid Quiet Market Response